Novoron’s History & Milestones
World MS Day 2020: Connecting the Multiple Sclerosis Community
A conversation focussed primarily on the importance of connecting multiple sclerosis (MS) researchers/scientists and people living with MS.
Mesenchymal Stem Cell Trial for Multiple Sclerosis
Interview with Dr. Travis Stiles and Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial for people living with multiple sclerosis.
Day 2 of the European Committee for Treatment and Research of Multiple Sclerosis Congress
Exciting stem cell trial results, progressive multiple sclerosis (MS), clinical trials, comorbidities and the treatment of symptoms were some of the key topics explored on Day 2.
Day 1 of the annual European Committee for Treatment and Research in Multiple Sclerosis
Topics covered include HSCT, remyelination, imaging and the role of environmental factors.
Novoron Bioscience - Reversing Central Nervous System Disorders + Diseases (feat. Travis Stiles)
Hear the story behind Backstage Capital Headliner Novoron Bioscience, a San Diego-based biotech company developing novel therapeutic approaches to address disorders of the central nervous system.
Developing Next Gen Multiple Sclerosis Therapies: Part 5
We are going to parse out myth vs. reality, explain how we address the innovation gap, and how we can improve the system to make the best possible drugs for the future.
Developing Next Gen Multiple Sclerosis Therapies: Part 4
In this article, we will discuss the different players involved in medical innovation, including their roles (and how those roles have evolved over time).
Developing Next Gen Multiple Sclerosis Therapies: Part 3
Now that we have set the stage with the drug development process, we can begin to examine possible ways to adapt the system and improve outcomes. We know that the rate of new therapies and cures has slowed, so how can we right the ship and accelerate innovation?
Developing Next Gen Multiple Sclerosis Therapies: Part 2
So how exactly does a drug come to the market?
Developing Next Gen Multiple Sclerosis Therapies: Part 1
For most people, medicine can be another language. It can be intimidating, even scary. However, modern medicine can also be miraculous and a tremendous source of hope.
Funding the Cure with Dr Travis Stiles part 2 - MS & ME Interviews
Part two of the interview with Dr. Travis Stiles in the MS & ME interview series.
Funding the Cure with Dr Travis Stiles part 1 - MS & Me Interviews
Multiple Sclerosis Auckland Research Day 2016: Dr Travis Stiles (full presentation)
Dr Travis Stiles (CEO, Novoron Bioscience) presented at the Multiple Sclerosis Auckland Research Day 2016 to discuss remyelination and the drug design process.
Novoron CEO Addresses MS Groups in New Zealand
Dr. Travis Stiles, Novoron's CEO and President, delivered presentations on remyelination and Novoron's novel drug development program in New Zealand last weekend.
Interview: Remyelination in MS with Novoron Bioscience
Brett Drummond interviews Dr. Travis Stiles on Remyelination in MS.